252 results
Page 3 of 13
8-K
EX-99.1
vcspjr a9ebhhszv3
16 May 22
Adamis Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:44pm
8-K
EX-99.1
6nsi1rvn8xhx ki6
31 Mar 22
Adamis Pharmaceuticals Reports Full Year 2021 Financial Results and Provides Corporate Update
5:02pm
8-K
EX-14.1
j86z6uug
18 Feb 22
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:43pm
8-K
bkmbpehighwmdu
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
EX-99.1
q21z7uksu l3jqh0
10 Jan 22
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
4:31pm
8-K
EX-99.1
yakli3r7k rf49drn7w0
22 Nov 21
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
5:00pm
8-K
EX-99.1
5w502z
18 Oct 21
Adamis Receives FDA Approval for ZIMHI
4:41pm
8-K
EX-99.1
w99d07o a352x
24 Aug 21
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
5:06pm
DEFA14A
49n3pdbq
13 Jul 21
Additional proxy soliciting materials
8:27am
DEFA14A
3t11aaav29 vx
13 Jul 21
Additional proxy soliciting materials
6:04am
8-K
EX-99.1
qd9tte st
13 Jul 21
Investor Presentation July 2021
6:02am
DEFA14A
bvpg1l 7tr
1 Jul 21
Additional proxy soliciting materials
8:20am
DEFA14A
mjasir7 i5xmgd
28 Jun 21
Additional proxy soliciting materials
7:31am
DEFA14A
a91ercfvt0du74xl6
14 Jun 21
Additional proxy soliciting materials
10:32am
8-K
EX-99.1
e9s0rysamionm1vqt4
15 Apr 21
Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
5:03pm